Clinical Trial Update: Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating lenalidomide with prednisone in low and int-1 risk non-5q myelodysplastic syndrome has completed with results posted in 2016…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Lenalidomide (lenalidomide)
• PREDNISONE (Prednisone)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Myelodysplastic Syndrome, MDS | Phase 2 | Status: COMPLETED | Results posted: 2016-01-18